Overview Financials Chart Business Summary Filings Ownership Valuation

← Scroll for more →

Financial Statements — KNSA

Balance Sheet

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Cash & Equivalents	81.66	175.68	189.95	165.60	174.86	192.04	157.13	183.58	97.38	99.27	141.08	107.95	117.83	112.57	80.62	122.72	175.76	94.31	63.32	122.47
Short-term Investments	487.10	350.25	278.14	248.48	177.24	115.75	111.21	60.05	126.40	119.49	72.47	98.42	83.26	72.43	106.88	67.89	24.96	43.90	82.25	59.73
Accounts Receivable	30.78	23.49	23.22	15.59	51.74	31.91	40.07	41.72	24.89	20.45	16.00	21.27	3.04	24.65	7.42	12.66	11.16	7.81	29.44	3.99
Inventory	108.03	70.93	73.14	54.90	41.40	48.18	22.07	26.36	28.68	34.86	27.28	31.12	25.58	23.96	23.43	21.60	14.62	19.92	13.22	3.68
Total Current Assets	750.10	668.63	594.17	527.18	475.53	420.31	355.91	331.80	311.30	301.02	270.59	276.30	256.11	246.04	231.50	243.06	241.82	179.94	198.76	196.45
Property, Plant & Equipment	2.46	2.58	1.99	1.94	1.66	1.08	0.61	0.66	0.56	0.63	0.71	0.73	0.92	1.14	1.39	1.66	2.00	2.15	2.48	2.83
Intangible Assets	14.50	14.75	15.00	15.25	15.50	15.75	16.00	16.25	16.50	16.75	17.00	17.25	17.50	17.75	18.00	18.25	18.50	18.75	19.00	19.25
Total Non-current Assets*	233.14	227.48	231.11	236.46	236.80	240.84	243.42	248.75	244.00	241.41	249.08	250.03	226.95	238.29	211.36	216.61	218.14	30.64	32.21	36.35
Total Assets	983.24	896.11	825.28	763.63	712.33	661.15	599.33	580.55	555.30	542.43	519.67	526.32	483.06	484.33	442.86	459.67	459.95	210.58	230.97	232.80
Accounts Payable	4.11	12.40	24.40	2.03	6.15	8.96	1.98	2.04	8.33	7.39	5.63	8.25	1.01	0.65	1.39	7.90	1.47	2.52	3.38	1.87
Total Current Liabilities	191.86	171.25	156.61	139.18	123.59	117.83	97.27	100.62	95.96	84.29	64.21	63.67	53.47	47.47	36.59	47.07	56.49	43.54	50.35	44.82
Total Non-current Liabilities*	81.19	70.71	62.98	56.84	53.36	48.32	44.57	41.50	22.34	23.04	23.57	23.82	24.47	25.20	16.18	16.46	19.45	13.54	14.37	2.94
Total Liabilities	273.05	241.96	219.59	196.03	176.95	166.14	141.84	142.12	118.29	107.33	87.78	87.48	77.94	72.68	52.77	63.52	75.94	57.08	64.72	47.76
Retained Earnings	(366.77)	(414.11)	(439.55)	(462.14)	(476.34)	(494.77)	(512.60)	(521.14)	(512.25)	(499.56)	(495.65)	(477.95)	(503.19)	(489.33)	(504.30)	(492.03)	(496.49)	(720.59)	(700.61)	(675.40)
Total Stockholder Equity	710.19	654.15	605.69	567.61	535.38	495.01	457.49	438.44	437.01	435.10	431.90	438.84	405.13	411.66	390.10	396.15	384.01	153.49	166.24	185.04

← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Total Revenue	285.97	243.60	214.27	202.13	180.86	156.80	137.79	122.54	112.21	108.63	79.86	83.40	67.05	71.47	48.35	61.88	99.14	26.97	32.19	18.75
Cost of Revenue*	27.76	23.57	20.80	20.95	20.26	18.60	17.87	17.90	20.11	12.32	10.58	9.58	9.09	7.70	7.04	6.71	6.94	--	--	3.87
Gross Profit	258.21	220.03	193.47	181.18	160.60	138.19	119.92	104.64	92.11	96.31	69.28	73.81	57.96	63.77	41.31	55.17	92.20	--	--	14.88
Research & Development	32.79	40.90	27.48	34.61	24.17	18.75	19.33	35.22	26.06	24.02	26.33	20.05	17.11	23.77	15.17	14.39	16.49	13.80	20.82	27.43
Selling, General & Admin	65.36	63.87	61.15	56.78	49.10	46.86	43.53	40.53	46.40	42.40	38.68	36.74	34.47	29.18	29.05	27.22	24.68	23.84	22.22	22.74
Total Operating Expenses	203.98	192.83	164.20	161.41	136.58	118.03	106.65	123.94	101.76	96.43	85.82	73.73	68.89	66.93	52.51	49.13	45.79	--	--	51.01
Operating Income	54.24	27.19	29.27	19.77	24.02	20.16	13.27	(19.30)	(9.66)	(0.12)	(16.54)	0.08	(10.93)	(3.15)	(11.20)	6.05	46.41	(19.37)	(23.32)	(36.13)
Pretax Income	59.06	31.15	32.68	23.27	27.16	22.88	15.57	(16.98)	(7.20)	2.30	(14.28)	2.45	(8.50)	(1.24)	(9.36)	6.84	46.74	(19.26)	(23.28)	(36.05)
Tax Provision	11.71	5.71	10.09	9.07	8.72	5.05	7.03	(8.09)	5.49	6.21	3.43	(22.79)	5.36	(16.21)	2.91	2.38	(177.36)	0.72	1.93	0.28
Net Income	47.35	25.43	22.59	14.20	18.43	17.83	8.54	(8.89)	(12.69)	(3.91)	(17.70)	25.24	(13.85)	14.97	(12.27)	4.46	224.09	(19.98)	(25.21)	(36.33)
Basic EPS	0.61	0.33	0.30	0.19	0.25	0.24	0.12	(0.11)	(0.18)	(0.06)	(0.25)	0.37	(0.20)	0.21	(0.18)	0.06	3.23	(0.29)	(0.36)	(0.53)
Diluted EPS	0.56	0.30	0.27	0.18	0.23	0.23	0.11	(0.11)	(0.18)	(0.06)	(0.25)	0.37	(0.20)	0.21	(0.18)	0.07	3.18	(0.29)	(0.36)	(0.53)

← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Operating Cash Flow	47.55	47.20	50.20	53.89	33.68	28.09	22.32	18.77	(2.24)	5.17	3.99	4.33	16.99	(3.74)	(4.27)	(11.58)	62.05	(7.82)	(36.85)	(18.88)
Capital Expenditures	0.18	0.66	0.16	0.63	0.67	0.17	0.10	0.19	0.00	0.00	0.08	0.06	0.02	0.03	0.02	(0.03)	0.02	0.12	--	0.25
Free Cash Flow*	47.37	46.53	50.04	53.26	33.01	27.93	22.23	18.58	(2.24)	5.17	3.90	4.27	16.97	(3.78)	(4.29)	(11.54)	62.03	(7.94)	--	(19.14)
Investing Cash Flow	(138.56)	(73.58)	(31.92)	(70.81)	(62.75)	(3.88)	(51.54)	65.29	(6.35)	(46.80)	25.52	(14.89)	(12.28)	35.53	(37.92)	(42.66)	19.04	38.27	(22.72)	(50.04)
Financing Cash Flow	(3.00)	12.11	6.07	7.66	11.90	10.70	2.77	2.14	6.69	(0.18)	3.61	0.70	0.55	0.16	0.09	1.19	0.36	0.54	0.42	1.21

← Scroll for more columns →

* Derived from reported values